Brivanib Uses, Dosage, Side Effects and more
Brivanib is under investigation for the treatment of HepatoCellular Carcinoma. Brivanib has been investigated for the treatment of Solid Tumors, Hepato Cellular Carcinoma (HCC), and Metastatic Colorectal Cancer (MCRC).
| Trade Name | Brivanib |
| Generic | Brivanib |
| Brivanib Other Names | Brivanib |
| Type | |
| Formula | C19H19FN4O3 |
| Weight | Average: 370.384 Monoisotopic: 370.144118651 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
